The Latest Cardiac and Vascular News
Vancouver, Nov. 07, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced the appointment of Bill Little […]
PRECISION-AF pivotal Phase 3 clinical trial initiation anticipated first quarter of 2020 Trial to examine atrial fibrillation in a heart failure population for which there are no FDA indicated drug therapies WESTMINSTER, Colo., Nov. 06, 2019 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach […]
SAN FRANCISCO, Nov. 6, 2019 /PRNewswire/ — Recardio Inc., a life science company developing regenerative therapies for cardiovascular diseases, announced that it has rolled out its digital platform, CardioCare, throughout Europe to support its future clinical development programs in cardiovascular. Recardio’s Digital Platform CardioCare was awarded and presented at the ESC Conference 2018 and is now […]
– Company to Present Preliminary Data at American Heart Association Scientific Sessions – GERMANTOWN, Md., Nov. 7, 2019 /PRNewswire/ — Triple-Gene LLC, a clinical stage cardiovascular gene therapy company and majority owned subsidiary of Intrexon Corporation (NASDAQ: XON), today announced the completion of enrollment and dosing in its Phase 1 trial of INXN-4001, a […]
ST. LOUIS and PESSAC, France, Nov. 05, 2019 (GLOBE NEWSWIRE) — Stereotaxis (NYSE American: STXS) and inHEART today announced the first patients have been successfully treated with the integration of inHEART’s advanced preoperative mapping and Stereotaxis’ Robotic Magnetic Navigation technologies. inHEART applies advanced algorithms on preoperative CT and MRI images to generate highly detailed […]
NEW YORK–(BUSINESS WIRE)–Ninety One, Inc., an Augmented Intelligence company developing an innovative software and data science platform designed to automate Cardiac Remote Monitoring and further Precision Medicine, announced today that Dr. Andrea Natale, M.D., F.A.C.C., F.H.R.S., F.E.S.C., Executive Medical Director of Texas Cardiac Arrhythmia Institute at St. David’s Medical Center, has been […]
First-of-its-Kind Pivotal Study of the Tack Endovascular System® Demonstrates 100% Dissection Resolution in Challenging Below-the-Knee Disease WAYNE, Pa.–(BUSINESS WIRE)–Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the positive six-month results of its Tack Optimized Balloon Angioplasty (TOBA) II BTK clinical trial, successfully achieving all primary (P < 0.0001) […]
Novel technology offers physicians first and only real-time detection and monitoring of endovascular bleed complications HOUSTON–(BUSINESS WIRE)–Saranas, Inc. today announced completion of the first U.S. commercial case using the Early Bird® Bleed Monitoring System for real-time detection and monitoring of endovascular bleed complications. Dr. Robert Kipperman, co-director of the Structural Heart […]
Results Presented Today at Vascular Interventional Advances (VIVA) Conference PARIS–(BUSINESS WIRE)–LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), today announced the presentation of positive six-month data from the full patient cohort in […]
Exceeds Expectations Delivers Double Digit Revenue Growth MALVERN, Pa., Nov. 05, 2019 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the third quarter ended September […]
